| Price | $93.49 |
| Year Range | $79.37 – $101.38 |
| Market Cap | $17.8B |
| PE Ratio | 22.69 |
| Industry | Medical Devices |
What Is Zimmer Biomet’s AI Stock Analysis?
Zimmer Biomet’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Zimmer Biomet’s momentum in near-real time.
Zimmer Biomet (ZBH) has an AltIndex AI Score of 50/100, currently a Hold signal. The AI Score distills Zimmer Biomet's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Zimmer Biomet’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Zimmer Biomet — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving ZBH’s AI Score?
Fundamentals
Revenue for the last quarter was $2.18B. This is an increase of 4.33% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 4.80%, suggesting positive year-over-year growth. Net income for the last quarter was $198M. This represents a decrease of 16.72% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of 29.78%, suggesting positive year-over-year growth. Ebitda for the last quarter was $328M. This represents a decrease of 39.07% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 43.03%, which may be a cause for concern. The current P/E ratio is 22.69. This appears to be within a normal range, neither particularly high nor low.
See Zimmer Biomet’s earnings and insider transactions.
Technicals
Today's stock price is $93.49. This represents a decrease of 7.11% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 6.44%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $96.55, which is lower than the previous SMA10 of $97.14. This suggests a potential downward trend in price movement. The RSI is 37.6, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Zimmer Biomet has an estimated 580 open positions. This number is up by 11% in the last couple of months, indicating a company that looking to grow and expand. Potentially a healthy sign. The business outlook among employees at Zimmer Biomet is neutral. Zimmer Biomet has an estimate of 360,000 visitors to their webpage. The number of visitors is up by 29% in the last couple of months, a bullish trend as this can indicate can increase in customers.
Explore Zimmer Biomet’s job postings, web traffic and app downloads.
Sentiment & social
Zimmer Biomet has 12,000 followers on their Twitter page. The number of followers is down by -0% in the last couple of months, indicating a loss in interest in the company.
Track Zimmer Biomet’s market sentiment.
Frequently Asked Questions: Zimmer Biomet AI Stock Analysis
Zimmer Biomet's AltIndex AI Score is 50/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Zimmer Biomet a Hold (50/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Zimmer Biomet — company overview, fundamentals, technicals and alternative data, with a recommendation. See the ZBH AI Score or sign up to read the full thesis.
